CM
DVAX

Crestline Management’s Dynavax Technologies DVAX Stock Holding History

Crestline Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,000
Closed -$89K – 120
2020
Q2 		$89K Buy
+10,000
New +$50.5K 0.02% 157

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Crestline Management's DVAX Position: Q1 2025 in Review

Crestline Management sold out of Dynavax Technologies (DVAX) in Q1 2025, closing a stake of 452,455 shares — an estimated $5.78M sold.

Crestline Management first reported a position in DVAX in Q3 2024 and held it in 2 quarters. The position peaked at $5.78M in Q4 2024. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.

  • Crestline Management reported no remaining Dynavax Technologies position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 452,455 Dynavax Technologies shares in Q1 2025, an estimated $5.78M.
  • Crestline Management first reported a position in Dynavax Technologies in Q3 2024 and held it in 2 quarters.
  • Crestline Management's Dynavax Technologies position peaked at $5.78M in Q4 2024.
  • 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.